Alex Toker received a BSc from King's College, University of London, UK in 1987 and a PhD from the National Institute for Medical Research, London, UK in 1991. He conducted his post-doctoral research in the laboratory of Prof. Lewis Cantley, first in the Department of Physiology, Tufts University School of Medicine, then in the Department of Cell Biology, Harvard Medical School and Division of Signal Transduction, Beth Israel Deaconess Medical Center. His first faculty appointment was as Staff Scientist at the Boston Biomedical Research Institute in 1997, where he was promoted to Principal Scientist in 1999. In 2000 he joined the faculty of Beth Israel Deaconess Medical Center and Harvard Medical School as an Assistant Professor in the Department of Pathology. In 2003, he was promoted to Associate Professor and joined the faculty of the HMS PhD program in Biological and Biomedical Sciences. In 2010, he was promoted to Professor of Pathology at HMS.

Other Activities:

1. •  Vice Chair, Reviews, The Biochemical Journal
   

2. •  Editorial Board, Molecular and Cellular Biology 
   

3. •  Member of Faculty of 1000
   

4. •  Chair, Editorial Advisory Board, ASBMB Today

Alex Toker, PhD

Rebecca Chin, PhD

Sivan Elloul, PhD

Jessica Gasser

Emilie Collmann, PhD

Rebecca Chin Received her PhD from Albert Einstein College of Medicine. Her research focuses on the molecular mechanisms by which PI 3-K and Akt signaling promotes breast cancer invasion and metastasis. She is a recipient of a 2007 Susan G. Komen Breast Cancer Foundation award. In addition, Rebecca is a recipient of a Scholar-in-Training Award from the AACR and Aflac, Inc. (2009), and a recipient of an AACR Women in Cancer Research Award (2010). In December 2009, Rebecca was promoted to Instructor in Pathology at Harvard Medical School. In 2011, Rebecca received a K99 Howard Temin Award from the National Cancer Institute

Sivan Elloul received her PhD from the Hebrew University of Jerusalem. Her current research focuses on the Akt pathway and cell survival. She is a recipient of a 2010 DOD Breast Cancer Research Program post-doctoral fellowship award.

Jessica Gasser received her BS degree from the University of Illinois, Urbana/Champaign. Her research focuses on the PI 3-K and SGK pathway in the regulation of breast cancer progression. She is a recipient of a 2010 DOD Breast Cancer Research Program pre-doctoral fellowship award.

Emilie Collmann received her PhD from the University of Basel, Switzerland in the laboratory of Matthias Wymann. Her research focuses on the PI 3-K signaling pathway in cancer. She is a recipient of a 2011 Susan G. Komen For the Cure post-doctoral fellowship award.

Kristin Brown, PhD

Heather Gardiner

Heather Gardiner received her BS degree from Northeastern University. Heather is the Toker laboratory manager.

Aura Kaunisto, PhD

Aura Kaunisto received her PhD degree from the University of Turku and the Turku Graduate School of Biomedical Sciences in Finland in the laboratory of John E. Eriksson. Her research focuses on the NFAT pathway and genes that regulate tumor-stromal interactions. She is a recipient of 2010 Emil Aaltonen Foundation, 2010 Oskari Huttunen Foundation and 2010 Orion-Farmos Research Foundation fellowships.

Colin White, PhD

Colin White received his PhD degree from the University of Edinburgh, Edinburgh, Scotland. He was a post-doctoral fellow in the laboratory of Dr. David Sacks at the Brigham and Women’s Hospital at HMS from 2008 to 2010, and in 2011 joined the Toker lab. His work research focuses on IQGAP proteins in breast cancer progression. He is a recipient of a 2009 DOD Breast Cancer Research Program post-doctoral fellowship award. In October 2011, Colin was promoted to Instructor in Pathology at Harvard Medical School.

Whitney Henry

Whitney Henry received her BS degree from the Grambling State University, LA. Her research focuses on the PI 3-K and Akt pathway and control of transcriptional responses in breast cancer.